4th Quarter - Report

ADVOCATE HEALTH (FKA ADVOCATE AURORA HEALTH, INC.) for ADVOCATE HEALTH (FKA ADVOCATE AURORA HEALTH, INC.)

Firm
Client
Income
—
Expenses
$580,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Medicaid Funding; Health Care Innovation; Telehealth/Digital Health; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; Surprise Billing; Anti-Kickback Statute Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; Accountable Care Organizations; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs; COVID-19; Value in Health Care Act.

LobbyistCovered position, as disclosed
ANTHONY CURRY —
JILL DOWELL - EFFECTIVE 2/9/21 New —
THOMAS MCDANIELS New —
JOYCE ROGERS —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 987 (116th), H.R. 2150 (116th), H.R. 1499 (116th), H.R. 2753 (116th)

Medicare/Medicaid MMM

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Medicaid Funding; Health Care Innovation; Telehealth/Digital Health; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Statute Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; Accountable Care Organizations; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs; COVID-19; Value in Health Care Act

LobbyistCovered position, as disclosed
ANTHONY CURRY —
JILL DOWELL - EFFECTIVE 2/9/21 —
THOMAS MCDANIELS New —
JOYCE ROGERS —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: S. 916 (116th), H.R. 1897 (116th), H.R. 2150 (116th), H.R. 1499 (116th), H.R. 2753 (116th), H.R. 987 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.